This proposal is designed to fill a gap in our knowledge of the negative regulation of proliferation in cells of epithelial origin, the cell type in which the majority of human tumors occur. The MK mouse keratinocyte cell line provides an excellent model for these studies, as the cells are relatively easily obtained, possess many characteristics of normal keratinocytes, and both the positive and negative growth factor regulation has been characterized. Since it has been speculated that a loss of normal inhibitory signals may play a role in the expression of a malignant phenotype in epithelial cells, the proposed studies will concentrate on the actions of the antiproliferative growth factor, transforming growth factor type beta (TGF beta). The available evidence suggests that TGF Beta may exert its inhibitory effect by modulating levels of key RNA species that control cell proliferation. The molecular basis of TGF beta-mediated inhibition of growth will therefore be approached using hybridization-subtraction or differential screening of cDNA libraries from TGF Beta treated and untreated cells, methods that have been previously used to identify a number of potentially interesting genes involved in cellular proliferation, transformation, and differentiation. The experiments will be designed to identify genes that are induced by TGF Beta that may inhibit cellular growth (TGF Beta-inducible genes, TIGs), as well as genes required for proliferation that are repressed by TGF Beta (TGF Beta-repressible genes, or TRGs). Cell transfection experiments will be performed to differentiate between genes that play a direct, causal role in regulating cell proliferation from those altered as a consequence of the growth state. These experiments will identify genes that are necessary, and perhaps sufficient, for growth factor regulation of MK cell proliferation. Characterization of TGF Beta-modulated genes will provide a better understanding of the molecular regulation of epithelial cell growth and may ultimately aid in devising rational approaches to preventing or managing the uncontrolled growth characteristic of malignant neoplasia.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA048799-03
Application #
3808006
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Satterwhite, D J; White, R L; Aakre, M E et al. (2001) TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1. Pediatr Res 50:67-75
Engel, M E; McDonnell, M A; Law, B K et al. (1999) Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274:37413-20
Norgaard, P; Law, B; Joseph, H et al. (1999) Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Clin Cancer Res 5:35-42
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Gorska, A E; Joseph, H; Derynck, R et al. (1998) Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9:229-38
Alexandrow, M G; Moses, H L (1998) c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. J Cell Biochem 70:528-42
Zhao, G Q; Liaw, L; Hogan, B L (1998) Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 125:1103-12
Engel, M E; Datta, P K; Moses, H L (1998) RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J Biol Chem 273:9921-6
Datta, P K; Chytil, A; Gorska, A E et al. (1998) Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 273:34671-4
Serra, R; Johnson, M; Filvaroff, E H et al. (1997) Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-52

Showing the most recent 10 out of 62 publications